ACCESS Newswire
24 Nov 2022, 11:49 GMT+10
GOTHENBURG, SE / ACCESSWIRE / November 24, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 24, 2022 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson's disease, today announced that the company will present and participate at Redeye Life Science Day 2022 on Thursday, November 24, 2022.
Richard Godfrey, CEO, will participate in an interview segment at 11:40 CET on Thursday, November 24, 2022. A pre-recorded company presentation is available via the event platform. Follow the live broadcast at https://www.redeye.se/events/850947/redeye-life-science-day.
A recording of the interview and presentation will be made available on our company website, www.irlab.se, following the event.
For more information:
Richard Godfrey, CEO
Phone: +46 730 70 69 00
E-mail: [email protected]
About IRLAB
IRLAB discovers and develops novel treatments of Parkinson's disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam.
IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its proprietary systems biology-based Integrative Screening Process (ISP) research platform. In addition to IRLAB's strong clinical pipeline, the company is also progressing two preclinical programs, IRL942 and IRL757, towards Phase I studies. IRLAB is listed on Nasdaq Stockholm. More information on www.irlab.se.
Attachments
IRLAB to present at Redeye Life Science Day 2022
SOURCE: IRLAB Therapeutics
Get a daily dose of Tennessee Daily news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Tennessee Daily.
More InformationLOS ANGELES, California: Model Hailey Bieber's skincare and makeup brand, Rhode, is being bought by Elf Beauty for around US$1 billion....
PARIS, France: Aircraft delivery delays at Airbus are now expected to stretch into 2028, as the European planemaker continues to grapple...
GRAPEVINE, Texas: GameStop has taken a significant step into the world of cryptocurrencies, revealing this week that it has purchased...
NEW YORK CITY, New York: Rising mortgage rates and economic uncertainty are leaving many Americans unsure about whether to buy a home—just...
SAN FRANCISCO, California: Texas is set to become the first major U.S. state to require Apple and Google to verify the age of users...
WASHINGTON, D.C.: After months of steady decline, U.S. consumer confidence saw a significant rebound in May—buoyed in part by a temporary...
WASHINGTON, D.C.: U.S. federal officials are looking into an attempt by someone who pretended to be White House Chief of Staff Susie...
LOS ANGELES, California: Model Hailey Bieber's skincare and makeup brand, Rhode, is being bought by Elf Beauty for around US$1 billion....
SEATTLE, Washington: Amazon has struck a significant deal with The New York Times to license its journalism for use in AI tools like...
GRAPEVINE, Texas: GameStop has taken a significant step into the world of cryptocurrencies, revealing this week that it has purchased...
NEW YORK CITY, New York: Rising mortgage rates and economic uncertainty are leaving many Americans unsure about whether to buy a home—just...
SAN FRANCISCO, California: Texas is set to become the first major U.S. state to require Apple and Google to verify the age of users...